Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Hoppe, RT; Advani, RH; Ai, WZ; Ambinder, RF; Armand, P; Bello, CM; Benitez, CM; Bierman, PJ; Boughan, KM; Dabaja, B; Gordon, LI; Herrera, AF ...
Published in: J Natl Compr Canc Netw
June 2020
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2020
Volume
18
Issue
6
Start / End Page
755 / 781
Location
United States
Related Subject Headings
- Young Adult
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Staging
- Middle Aged
- Humans
- Hodgkin Disease
- Guidelines as Topic
- Adult
- Adolescent
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoppe, R. T., Advani, R. H., Ai, W. Z., Ambinder, R. F., Armand, P., Bello, C. M., … Ogba, N. (2020). Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(6), 755–781. https://doi.org/10.6004/jnccn.2020.0026
Hoppe, Richard T., Ranjana H. Advani, Weiyun Z. Ai, Richard F. Ambinder, Philippe Armand, Celeste M. Bello, Cecil M. Benitez, et al. “Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 6 (June 2020): 755–81. https://doi.org/10.6004/jnccn.2020.0026.
Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, et al. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Jun;18(6):755–81.
Hoppe, Richard T., et al. “Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 18, no. 6, June 2020, pp. 755–81. Pubmed, doi:10.6004/jnccn.2020.0026.
Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, McKinney M, Metzger M, Morgan D, Mulroney C, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Jun;18(6):755–781.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
June 2020
Volume
18
Issue
6
Start / End Page
755 / 781
Location
United States
Related Subject Headings
- Young Adult
- Prognosis
- Oncology & Carcinogenesis
- Neoplasm Staging
- Middle Aged
- Humans
- Hodgkin Disease
- Guidelines as Topic
- Adult
- Adolescent